Drugs / MF59 adjuvanted H1N1 influenza monovalent vaccine
MF59 adjuvanted H1N1 influenza monovalent vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01031966 Comparator | Nov 2009 → May 2010 | end stage renal failure | sigma-tau i.f.r. S.p.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59 adjuvanted H1N1 influenza monovalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01031966 ↗ |
| Modality | Vaccine | “Biological: MF59 adjuvanted H1N1 influenza monovalent vaccine” NCT01031966 ↗ |